Ferdynand Kos

927 citations
15 papers · 725 indexed · h-index 12
Topics
Immunotherapy and Immune Responses (7 papers)Immune Cell Function and Interaction (5 papers)T-cell and B-cell Immunology (4 papers)

In The Last Decade

Ferdynand Kos

15 papers receiving 704 citations

Peers

Ferdynand Kos
Comparison fields: 5 of 80
  • Immunology 501
  • Oncology 241
  • Epidemiology 227
  • Molecular Biology 158
  • Surgery 43
Replace Karen Brajão de Oliveira with:
Karen Brajão de Oliveira Brazil
Marcus Pericin Switzerland
M. E. Christine Lutsiak United States
Thu Chau Canada
Joyce B. Reome United States
Julie Dierksheide United States
Todd A. Braciak Germany
Andrea L. George United States
Sergiusz Markowicz Poland
Kylie McDonald Australia
Ferdynand Kos relative to Karen Brajão de Oliveira Brazil Karen Brajão de Oliveira's profile →
Citations per field
00.5×1.6×
Karen Brajão de Oliveira · 1×
Citations per year

Countries citing papers authored by Ferdynand Kos

Since Specialization
Citations

This map shows the geographic impact of Ferdynand Kos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferdynand Kos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferdynand Kos more than expected).

Fields of papers citing papers by Ferdynand Kos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferdynand Kos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferdynand Kos. The network helps show where Ferdynand Kos may publish in the future.

Co-authorship network of co-authors of Ferdynand Kos

This figure shows the co-authorship network connecting the top 25 collaborators of Ferdynand Kos. A scholar is included among the top collaborators of Ferdynand Kos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferdynand Kos. Ferdynand Kos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 54
3 56
4 12
5 17
6 18
7 58
8 19
9 3
10 96
11 49
12 37
13 164
14 136
15 5

About Ferdynand Kos

Ferdynand Kos is a scholar working on Immunology, Genetics and Oncology, having authored 15 papers that have together received 725 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Immune Cell Function and Interaction (5 papers) and T-cell and B-cell Immunology (4 papers). The work is most often cited by research in Immunology (501 citations), Oncology (241 citations) and Epidemiology (227 citations). Ferdynand Kos has collaborated with scholars based in United States, Australia and Nepal. Frequent co-authors include E G Engleman, Cornelia L. Trimble, Shiwen Peng, T.‐C. Wu, Elizabeth A. Sugar, Christopher J. Thoburn, Raphael P. Viscidi, Drew M. Pardoll, Patti E. Gravitt and Don J. Diamond. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026